
Modern intrauterine devices (IUDs) are safe, effective, and quickly reversible long-term contraceptives that require little attention after insertion. Yet safety concerns and programmatic challenges have held back IUD services in many countries. New assessment of research findings, recently translated into guidance by the World Health Organization, should help reassure providers that most women can use IUDs safely.
Use of the IUD is safer than pregnancy and more effective in preventing pregnancy than oral contraceptives condoms spermicides barrier methods or natural family planning. The current generation of IUDs is safe for most women and about 99% effective over 1 year of use. Not all women should use IUDs. The provider must screen potential users insert the IUD correctly and follow up the users. Background information IUD performance data description of complications and insertion and removal procedures provider medical information descriptions and photographs of various types of IUDs discussion of IUD distribution and use internationally and the role of the device in family planning programs as well as highlighted guidelines in the choice of an IUD the warning signs and the counseling of users are provided in this report.
This discussion of IUDs covers the following: usage shifts to copper IUDs; issues for the 1980s; comparing the Lippes Loop and copper IUDs; life span of copper devices; steroid releasing IUDs; donor agency supplies; types of devices used; insertion and removal (timing of interval insertion postpartum insertion postabortion insertion postcoital insertion measuring the uterus removal and insertion by nurse midwives and paramedicals); bleeding (risk of anemia limited bleeding); infection (mechanisms of infection prevention treatment actinomyces); pregnancy (uterine pregnancies ectopic pregnancies differences among devices and subsequent fertility); product and packaging issues (manufacture in developing countries prices bulk and individual packaging methods of sterilizing IUDs and storage). At this time about 60 million women worldwide are using IUDs including over 40 million in China. In recent years the total number of users has remained relatively stable. The life table event rates per 100 women by which IUDs are usually evaluated are approximately as follows after 1 year of use in large multicenter studies: pregnancy 0.5-5; expulsion 5-15; removal for bleeding/pain (5-15); removal for other medical reasons 3-9; and removel for personal reasons 1-6. Continuation rates 1 year after insertion tend to range from 50-85% high rates for a reversible mothed. Some shift in usage occurred in the late 1970s from unmedicated Lippes Loop to copper releasing IUDs and to a lesser extent to IUDs that release progestins into the uterine cavity. Copper devices now have captured much of the market in the US and Western europe and amount to about 2/3 of the supplies provided by donor agencies to many developing countries. During the 1980s attention should probably focus less on the search for an ideal device and more on the need for family planning programs to identify suitable candidates for IUDs encourage better health service support for IUD insertion and follow-up and the newer IUDs more widely available to individuals and national programs. In most developing countries the great majority of IUDs are supplied by various national and international donor agencies that purchase large quantities at the lowest possible price and ship them to government and private programs. No data are available on the number of each type of IUD currently in use. Proper insertion of an IUD is important. Insertion can affect all major events that determine success. While there are several different techniques for inserting IUDs with each the skill of the operator is critical. Recent studies fo about 10000 women show that there is no one preferable time for insertion.
After nearly two decades of use, the IUD remains "a generally safe, effective and useful form of birth control" (337). With fewer than six pregnancies per 100 women-years of use and fewer than ten deaths per one million women-years of use, according to a comprehensive new review by the United States Food and Drug Administration, the IUD has an important place in modern family planning programs.
A decade of international experience with the intrauterine device (I UD) is reviewed. It is estimated that 15 million IUDs are being worn throughout the world. The Lippes loop D is perhaps the most effective IUD in use. The Copper T and Cu-7 devices are appropriate for nulliparous women. The IUD apparently has a differing mode of action from species to species. In humans the IUD does not interfere with ovulation corpus luteum formation or to some extent sperm transport and fertilization. However they do seem to inhibit implantation possibly through a non-inflammatory cell reaction in the uterus. IUDs are the primary contraceptive method in at least 10 countries including Taiwan and Korea. However the experience in India and Pakistan has not met initial expectations. The insertion procedure and equipment used are described. The ideal time for insertion is after abortion or pregnancy. Otherwise the last few days of menstruation is the best time. General or local anesthesia paracervical block or analgesia are not required for IUD insertion since the procedure is generally not painful. Perforation of the uterus is the most frequent complication during insertion. Net pregnancy rates for IUDs range from 0-5.6 per 100 women during the 1st year of use. The tendency now is to remove an IUD if pregnancy occurs. IUD expulsion rates range from .7-19.3 per 100 insertions after 1 year of use. Removals in the 1st year for bleeding and/or pain range from 4-14.7 per 100 women-years of use. Pelvic inflammatory disease (PID) is the 2nd most frequent reason for removal of an IUD. It is not clear whether the IUD increases the risk of PID. In the United States pelvic infection is the most common IUD-related symptom requiring hospitalization. 7 of 10 deaths associated with an IUD were the result of pelvic infection. The Dalkon Shield poses the most serious risks related to septic abortion and is no longer being distributed. The USAID distributed 5367310 IUDs during 1969-1974. The new copper-bearing IUDs cause less bleeding than inert devices. The replacement of copper wire with copper sleeves lengthens the life of copper-bearing IUDs. Some of the new devices being tested include Progestasert (progesterone-releasing) the intrauterine membrane the Spring Coil and the spring steel Ypsilon. Photographs of and data on various IUDs are appended.